Enzypep

company

About

Enzypep designs and develops oligopeptides for pharmaceutical products.

  • 1 - 10

Details

Last Funding Type
Funding Round
Industries
Biotechnology,Genetics,Health Care,Life Science,Manufacturing
Founded date
Jan 1, 2012
Number Of Employee
1 - 10
Operating Status
Active

Enzypep designs and develops oligopeptides for pharmaceutical products. The Enzypep technology is expected to become the state-of-the-art in design and preparation of complex peptides.

Compared with standard synthesis it results in pharmaceutical products with a much higher purity, at a much lower cost and in a sustainable, environmentally-friendly manner. It began operation in 2012, with its headquarters in Geleen in the Netherlands.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Enzypep has raised a total of — in funding over 2 rounds. Their latest funding was raised on Jan 1, 2014 from a Funding Round round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 1, 2014 Funding Round 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
Enzypep is funded by 2 investors. Nedermaas Hightech Ventures and Limburg Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Nedermaas Hightech Ventures Funding Round
Limburg Ventures Funding Round